Literature DB >> 23352574

Development and application of tools for Monte Carlo based simulations in a particle beam radiotherapy facility.

T Tessonnier1, A Mairani, F Cappucci, A Mirandola, G Vilches Freixas, S Molinelli, M Donetti, M Ciocca.   

Abstract

The integration of Monte Carlo (MC) transport codes into a particle therapy facility could be more easily achieved thanks to dedicated software tools. MC approach has been applied to several purposes at CNAO (Centro Nazionale di Adroterapia Oncologica), such as database generation for the treatment planning system, quality assurance calculations and biologically related simulations. In this paper we describe another application of the MC code and its tools by analyzing the impact of the dose delivery and range uncertainties on patient dose distributions.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Monte Carlo; Particle therapy; Tools

Mesh：

Year:  2013        PMID： 23352574     DOI： 10.1016/j.apradiso.2012.12.019

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN： 0969-8043            Impact factor:   1.513


  3 in total

1.  Dosimetric robustness against setup errors in charged particle radiotherapy of skull base tumors.

Authors:  Filippo Ammazzalorso; Urszula Jelen; Rita Engenhart-Cabillic; Wolfgang Schlegel
Journal:  Radiat Oncol       Date:  2014-12-05       Impact factor: 3.481

2.  The FLUKA Code: An Accurate Simulation Tool for Particle Therapy.

Authors:  Giuseppe Battistoni; Julia Bauer; Till T Boehlen; Francesco Cerutti; Mary P W Chin; Ricardo Dos Santos Augusto; Alfredo Ferrari; Pablo G Ortega; Wioletta Kozłowska; Giuseppe Magro; Andrea Mairani; Katia Parodi; Paola R Sala; Philippe Schoofs; Thomas Tessonnier; Vasilis Vlachoudis
Journal:  Front Oncol       Date:  2016-05-11       Impact factor: 6.244

3.  Phase Space Generation for Proton and Carbon Ion Beams for External Users' Applications at the Heidelberg Ion Therapy Center.

Authors:  Thomas Tessonnier; Tiago Marcelos; Andrea Mairani; Stephan Brons; Katia Parodi
Journal:  Front Oncol       Date:  2016-01-11       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.